15/06/2020
https://twitter.com/uroweb/status/1272389669968379905?s=21
“During follow-up, if mpMRI is negative (PI-RADS ≤ 2), and clinical suspicion of prostate cancer progression is low (low PSA velocity, long PSA doubling time), omit biopsy based on shared decision making with the patient. https://t.co/bfkImm1Hkl”